Live Breaking News & Updates on Samantha Floam

Stay updated with breaking news from Samantha floam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced five presentations, including two featured oral plenary presentations, on. ....

United States , New York , Nordrhein Westfalen , Hans Van Dongen , Mark Jacobson , Darren Opland , Michael Thorpy , Samantha Floam , Johannes Gutenberg , Department Of Neurology , Montefiore Medical Center , Professor At Washington State University , American Academy Of Sleep Medicine , Axsome Therapeutics Inc , Corporate Communications , Drug Administration , Medicine Center , University Witten Herdecke , World Trade Center , Wake Disorders Center , Research Society , Therapeutics Highlights Data , Solriamfetol Demonstrating Improvement , Cognitive Function , Obstructive Sleep Apnea , American Academy ,

Axsome to Present Findings on Solriamfetol's Cognitive Benefits

Axsome will unveil data demonstrating solriamfetol's ability to enhance cognitive functioning in patients with OSA and narcolepsy. ....

Nordrhein Westfalen , Johannes Gutenberg , Michael Thorpy , Solriamfetol Sunosi , Ulf Kallweit , Hans Van Dongen , Samantha Floam , Washington State University , Montefiore Medical Center , Wake Disorders Center , Department Of Neurology , Axsome Therapeutics Inc , Medicine Center , University Witten Herdecke , Axsome Therapeutics , Therapeutics Inc , Washington State , Yaroslav Winter , Mainz Comprehensive Epilepsy , Sleep Medicine Center , Johannes Gutenberg University , Sleep Wake Disorders Center , Albert Einstein College ,

Sunosi Improving Cognitive Function in OSA Patients with EDS

Sunosi (solriamfetol) is demonstrating improvement in cognitive function in patients with excessive daytime sleepiness associated with OSA. ....

United States , Eileen Leary , Samantha Floam , Drug Administration , American Society Of Clinical Psychopharmacology , Axsome Therapeutic Inc , American Society , Clinical Psychopharmacology , Annual Meeting , Cognitive Function , Cognitive Impairment Associated , Excessive Daytime Sleepiness , Obstructive Sleep Apnea , Daytime Sleepiness , Real World Study , Potential Mechanisms , Gregory Parks ,

Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Data on Auvelity demonstrating improved functioning in major depressive disorder Data on Sunosi demonstrating improved cognitive function in patients with excessive daytime sleepiness associated with. | May 30, 2023 ....

United States , New York , Gregory Mattingly , Rakesh Jain , Eileen Leary , Andrew Cutler , Samantha Floam , Darren Opland , Zachariah Thomas , Mark Jacobson , Clinical Professor Of Psychiatry At Washington University , Axsome Therapeutics Inc , Md Texas Tech University School Of Medicine , World Trade Center , National Survey On Drug , Sk Biopharmaceuticals Co Ltd , Neuroscience Education Institute , Midwest Research Group , National Institutes Of Health , American Society Of Clinical Psychopharmacology , Mental Health Services Administration , World Health Organization , Us Drug Enforcement Agency On , Drug Administration , Global Health , Behavioral Health Statistics ,

Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of SUNOSI® (solriamfetol) in Participants with Cognitive Impairment with Excessive Daytime Sleepiness in Obstructive Sleep Apnea at the 2023 American Academy of Neurology (AAN) Annual Meeting

NEW YORK, April 21, 2023 Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today. | April 21, 2023 ....

United States , United Kingdom , New York , Mark Jacobson , Stuartj Tepper , Axsome Mo , Darren Opland , Eileen Leary , Zachariah Thomas , Samantha Floam , Hans Van Dongen , Sk Biopharmaceuticals Co Ltd , Affairs At Axsome , Clinical Development At Axsome , Axsome Therapeutics Inc , Geisel School Of Medicine At Dartmouth , Corporate Communications , American Academy Of Neurology , Airway Pressure , Study Topline Data Press , Drug Administration , Professor At Washington State University , Us Drug Enforcement Agency On , Continuous Positive Airway Pressure , Annual Meeting , Participants During ,